Loading data
LABTNasdaq
| Unit: USD | FY2025 | FY2024 |
|---|---|---|
| Research and development expense | 1.26 m USD | 2.1 m USD |
| Operating profit | -3.77 m USD | -4.03 m USD |
| Net income (reported basis) | -3.8 m USD | -4.86 m USD |
| Net income attributable to common shareholders | -5.85 m USD | — |
| Basic earnings per share | -8.4 USD/share | -9.92 USD/share |
| Diluted earnings per share | -8.4 USD/share | -9.92 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.